Circulating electronegatively charged low‐density lipoprotein in patients with angiographically documented coronary artery disease

REFERENCES

• Ross R. The pathogenesis of atherosclerosis—an update. N Engl J Med 1986; 314: 488–500.
   PubMed Web of Science ®Google Scholar
• Steinberg D, Parthasaraty S, Carew TE, Khoo JC, Witztum JL. Beyond cholesterol: modifications of low density lipoprotein that increase its athero-genicity. N Engl J Med 1989; 320: 915–24.
   Google Scholar
• Sevanian A, Mead JF, Stein RA. Epoxides as products of lipid autoxidation in rat lungs. Lipids 1979; 14: 634–43.
   Google Scholar
• Smith LL. Another cholesterol hypothesis: chole-sterol as antioxidant. Free Rad Biol Med 1991; 11: 47–61.
   PubMed Web of Science ®Google Scholar
• Bhadra S, Arshad MAQ, Rymaszewski Z, Norman E, Wherley R, Subbiah MTR. Oxidation of cholesterol moiety of low density lipoprotein in the presence of human endothelial cells or Cu2+ ions: identification of major products and their effects. Biochem Biophys Res Commun 1991; 176: 431 — 40.
   PubMed Web of Science ®Google Scholar
• Jessup W, Rankin SM, de Whalley CV, Hoult JRS, Scott J, Leake DS. a-Tocopherol consump-tion during low-density-lipoprotein oxidation. Biochem J 1990; 265: 399–405.
   PubMed Web of Science ®Google Scholar
• Witztum JL. The oxidation hypothesis of athero-sclerosis. Lancet 1994; 344: 793–5.
   PubMed Web of Science ®Google Scholar
• Hoppe G, Ravandi A, Herrera D, Kuksis A, Hoff HF. Oxidation products of cholesteryl linoleate are resistant to hydrolysis in macrophages, form complexes with proteins, and are present in human atherosclerotic lesions. J Lipid Res 1997; 38: 1347–60.
   Google Scholar
• Lyons TJ. Glycation and oxidation: a role in the pathogenesis of atherosclerosis. Am J Cardiol 1993; 71: 26B–31B.
   Google Scholar
• Deckert V, Persegol L, Viens L, Lizard G, Athias A, Lallemant C, Gambert P, Lagrost L. Inhibitors of arterial relaxation among compo-nents of human oxidized low-density lipoproteins. Cholesterol derivatives oxidized in position 7 are potent inhibitors of endothelium-dependent relaxation. Circulation 1997; 95: 723— 31.
   Google Scholar
• Matthys KE, Van Hove CE, Kockx MM, Andries LJ, Van Osselaer N, Herman AG, Bult H. Exposure to oxidized low-density lipoprotein in vivo enhances intimal thickening and selectively impairs endothelium-dependent dilation in the rabbit. Cardiovasc Res 1998; 37: 239–46.
   PubMed Web of Science ®Google Scholar
• Harada-Shiba M, Kinoshita M, Kamido H, Shimokado K. Oxidized low density lipoprotein induces apoptosis in cultured human umbilical vein endothelial cells by common and unique mechanisms. J Biol Chem 1998; 273: 9681–7.
   Google Scholar
• Sevanian A, Hodis HN, Hwang J, McLeod LL, Peterson H. Characterization of endothelial cell injury by cholesterol oxidation products found in oxidized LDL. J Lipid Res 1995; 36: 1971 — 86.
   Google Scholar
• Hodis HN, Kramsch DM, Avogaro P, Bittolo-Bon G, Cazzolato G, Hwang J, Peterson H, Sevanian A. Biochemical and cytotoxic char-acteristics of an in vivo circulating oxidized low density lipoprotein (LDL—). J Lipid Res 1994; 35: 669— 77.
   Google Scholar
• Kritharides L, Jessup W, Gifford J, Dean RT. A method for defining the stages of low-density lipoprotein oxidation by the separation of cholesterol- and cholesteryl ester-oxidation products using HPLC. Anal Biochem 1993; 213: 79 — 89.
   PubMed Web of Science ®Google Scholar
• Szostak WB. Zasady wieloczynnikowej prewencji choroby niedokrwiennej serca. Kardiol Pol 1995; XLIV Suppl. II: 37–48.
   Google Scholar
• Redgrave TG, Roberts DC, West CE. Separation of plasma lipoproteins by density gradient ultra-centrifugation. Anal Biochem 1975; 65: 42–9.
   Google Scholar
• Knapp RG, Miller III MC. Clinical epidemiology and biostatistics. Baltimore, Maryland: Williams and Wilkins; 1992.
   Google Scholar
• Wood D, De Backer G, Faergeman O, Graham I, Mancia G, Pyörälä K. Prevention of coronary heart disease in clinical practice. Eur Heart J 1998; 19: 1434–503.
   Google Scholar
• Demuth K, Myara I, Chappey B, Vedie B, Pecg-Amsellem MA, Haberland ME, Moatti N. A cytotoxic electronegative LDL sub- fraction is present in human plasma. Arterioscler Thromb Vasc Biol 1996; 16: 773–83.
   PubMed Web of Science ®Google Scholar
• Skrzep-Poloezek B, Tomasik A, Tamawski R, Hyla-Klekot L, Dyduch A, Wojciechowska C, Wesotowski W, Kopieczna-Grzebieniak E, Zalejska-Fiolka J, Widera E. Nephrotic origin hyperlipidemia, relative reduction of vitamin E level and subsequent oxidative stress may promote atherosclerosis. Nephron 2001; 89: 68–72.
   Google Scholar
• Sevanian A, Hwang J, Hodis H, Cazzolato G, Avogaro P, Bittolo-Bon G. Contribution of an in vivo oxidized LDL to LDL oxidation and its association with dense LDL subpopulations. Arterioscler Thromb Vasc Biol 1996; 16: 784— 93.
   Google Scholar
• Holvoet P, Vanhaecke J, Janssens S, Van de Werf F, Collen D. Oxidized LDL and malondialdehyde-modified LDL in patients with acute coronary syndromes and stable coronary artery disease. Circulation 1998; 98: 1487–94.
   Google Scholar
• Ehara S, Ueda M, Naruka T, Haze K, Itoh A, Otsuka M, Komatsu R, Matsuo T, Itabe H, Takano T, Tsukamoto Y, Yoshiyama M, Takeuchi K, Yoshikawa J, Becker AE. Elevated levels of oxidized low density lipoprotein show a positive relationship with the severity of acute coronary syndromes. Circulation 2001; 103: 1955–60.
   Google Scholar
• Tsimikas S, Witztum JL. Measuring circulating oxidized low-density lipoprotein to evaluate coronary risk. Circulation 2001; 103: 1930–2.
   PubMed Web of Science ®Google Scholar